Marc S. Sabatine

Publishes on Lipoproteins and Cardiovascular Health, Diabetes Treatment and Management, Acute Myocardial Infarction Research. 975 papers and 121.2k citations.

PubIndex Score98Top 2%How it's scored

🌟#4 Current Senior Leader in Antiplatelet Therapy and Cardiovascular Diseases 🌟#9 Current Senior Leader in Diabetes Treatment and Management

975Publications

121.2kTotal Citations

#4in Antiplatelet Therapy and Cardiovascular Diseases

First publication: 1995First senior author: 2005

Lipoproteins and Cardiovascular Health Diabetes Treatment and Management Acute Myocardial Infarction Research Antiplatelet Therapy and Cardiovascular Diseases Coronary Interventions and Diagnostics

Top publicationsby citations

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray, Anna-Maria Langkilde, Scott D. Solomon et al.|New England Journal of Medicine|2019

Cited by 6.8k

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott, Marc S. Sabatine, Itamar Raz et al.|New England Journal of Medicine|2018

Cited by 6.3k

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Marc S. Sabatine, Terje R. Pedersen, Robert P. Giugliano et al.|New England Journal of Medicine|2017

Cited by 6k

Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

Marc P. Bonaca, Marc S. Sabatine, Deepak L. Bhatt et al.|New England Journal of Medicine|2015

Cited by 2k

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

Marc S. Sabatine, Evan A. Stein, Stephen D. Wiviott et al.|New England Journal of Medicine|2015

Cited by 1.5k